ArticleCureus2026
Apoptotic Colitis in a Liver Transplant Recipient: A Case of Solid Organ Transplant-Associated Graft-Versus-Host Disease.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Solid organ transplant-associated graft-versus-host disease (SOT-GVHD) is a rare but often fatal complication following liver transplantation. A 67-year-old man who underwent deceased donor liver transplantation subsequently developed progressive high-volume diarrhea and severe cytopenias with minimal initial cutaneous involvement. Colonic biopsy demonstrated apoptotic colitis with minimal lamina propria inflammation, suggestive of lower gastrointestinal (GI) GVHD. Donor-recipient chimerism analysis revealed significant donor-derived chimerism in peripheral blood and colonic tissue, confirming the diagnosis of SOT-GVHD. Maintenance immunosuppression was stopped to restore recipient immune function and eliminate donor-derived lymphoid cells; however, there was no clinical improvement. He was subsequently treated with high-dose systemic steroids, resulting in transient improvement. Despite this, he developed worsening diarrhea and pancytopenia, consistent with steroid-refractory GVHD, and passed away. This case emphasizes the need for a high index of suspicion for SOT-GVHD in liver transplant recipients presenting with gastrointestinal symptoms and cytopenias, even in the absence of significant early cutaneous manifestations. Histopathology and donor chimerism analysis of the involved tissue can aid in early diagnosis. Initial therapeutic approaches vary significantly, both withdrawing immunosuppression to elicit a host-versus-graft response and augmenting immunosuppression with systemic steroids have been described. Regardless, SOT-GVHD is associated with a high rate of mortality. Novel approaches for early diagnosis, prevention, and treatment are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.